Monday, 10 October 2011

Fenoget

Fenoget
(Fenofibrate)

Lipid-Adjusting Agent
Orally Administered Drug

Composition:



                                      Fenoget
Capsules

67 mg
200 mg
Amount of
Fenofibrate

67 mg

200 mg


The initial dose of Fenoget for kidney patients should be 67 mg per day and this dose should be increased only after evaluating its effects.

Fenoget is not suitable for use for:


  • Patients allergic to any constituent of the drug
  • Patients having severe kidney problems
  • Patients having liver problems
  • Breast-feeding mothers

Safety of use of this drug in infants has not been established.

Fenoget should be used during pregnancy only when the benefits of the drug-use outweigh the risks.

No comments:

Post a Comment

There was an error in this gadget